Whole-genome sequences of two influenza A (H3N2) virus strains isolated from Qinghai, China

Kilbourne, 2006, Influenza pandemics of the 20th century, Emerg. Infect. Dis., 12, 9, 10.3201/eid1201.051254 Hardy, 2001, Molecular evolution of influenza A/H3N2 viruses in the province of Quebec (Canada) during the 1997-2000 period, Virus Res., 77, 89, 10.1016/S0168-1702(01)00269-6 Bedford, 2014, Integrating influenza antigenic dynamics with molecular evolution, Elife, 3, e01914, 10.7554/eLife.01914 Osterholm, 2012, Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis, Lancet Infect. Dis., 12, 36, 10.1016/S1473-3099(11)70295-X Smith, 2004, Mapping the antigenic and genetic evolution of influenza virus, Science, 305, 371, 10.1126/science.1097211 Matrosovich, 2003, Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors, J. Virol., 77, 8418, 10.1128/JVI.77.15.8418-8425.2003 Cheng, 2017, Effect of Oseltamivir on the Hemagglutination test and Hemagglutination inhibition test of the influenza A(H3N2) virus in China, Chin. J. Virol., 33, 13 Deng, 2015, A simplified sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses, J. Clin. Virol., 68, 43, 10.1016/j.jcv.2015.04.019 Swindell,, 1997, SEQMAN. Contig assembly, Methods Mol. Biol., 70, 75 Hall, 1999, BioEdit: A user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT, Nucleic Acids Symp. Ser., 41, 95 Tamura, 2013, MEGA6: Molecular evolutionary genetics analysis version 6.0, Mol. Biol. Evol., 30, 2725, 10.1093/molbev/mst197 Schwede, 2003, SWISS-MODEL: An automated protein homology-modeling server, Nucleic Acids Res., 31, 3381, 10.1093/nar/gkg520 Kobasa, 2004, Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus, Nature, 431, 703, 10.1038/nature02951 Sun, 2013, Identification and characterization of avian-origin H3N2 canine influenza viruses in northern China during 2009-2010, Virology, 435, 301, 10.1016/j.virol.2012.09.037 Rambaut, 2008, The genomic and epidemiological dynamics of human influenza A virus, Nature, 453, 615, 10.1038/nature06945 Rossman, 2011, Influenza virus assembly and budding, Virology, 411, 229, 10.1016/j.virol.2010.12.003 Gen, 2013, Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice, Arch. Virol., 158, 1003, 10.1007/s00705-012-1577-3 Colman, 1993, Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase, J. Virol., 67, 2972, 10.1128/jvi.67.6.2972-2980.1993 Yen, 2006, Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses, J. Virol., 80, 8787, 10.1128/JVI.00477-06 Hui, 2003, Conserved cysteine and histidine residues in the putative zinc finger motif of the influenza A virus M1 protein are not critical for influenza virus replication, J. Gen. Virol., 84, 3105, 10.1099/vir.0.19389-0 Potdar, 2014, Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011, Indian J. Med. Res., 140, 244 Thippamom, 2010, Genetic variations of nucleoprotein gene of influenza A viruses isolated from swine in Thailand, Virol. J., 7, 185, 10.1186/1743-422X-7-185 Jackson, 2008, A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity, Proc. Natl. Acad. Sci. U. S. A., 105, 4381, 10.1073/pnas.0800482105 Gabriel, 2005, The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host, Proc. Natl. Acad. Sci. U. S. A., 102, 18590, 10.1073/pnas.0507415102 Krumbholz, 2011, Current knowledge on PB1-F2 of influenza A viruses, Med. Microbiol. Immunol., 200, 69, 10.1007/s00430-010-0176-8 Weis, 1988, Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid, Nature, 333, 426, 10.1038/333426a0 Wilson, 1990, Structural basis of immune recognition of influenza virus hemagglutinin, Annu. Rev. Immunol., 8, 737, 10.1146/annurev.iy.08.040190.003513 Vigerust, 2007, N-linked glycosylation attenuates H3N2 influenza viruses, J. Virol., 81, 8593, 10.1128/JVI.00769-07 Shil, 2011, Antigenic variability in neuraminidase protein of influenza A/H3N2 vaccine strains, Bioinformation, 7, 76, 10.6026/97320630007076 Duval, 2010, Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial, PLoS Med., 7, e1000362, 10.1371/journal.pmed.1000362 Deyde, 2007, Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide, J. Infect. Dis., 196, 249, 10.1086/518936 Arias, 2009, Molecular anatomy of 2009 influenza virus A (H1N1), Arch. Med. Res., 40, 643, 10.1016/j.arcmed.2009.10.007 Katz, 2000, Molecular correlates of influenza A H5N1 virus pathogenesis in mice, J. Virol., 74, 10807, 10.1128/JVI.74.22.10807-10810.2000 Shi, 2019, Co-circulation and persistence of multiple A/H3N2 influenza variants in China, Emerg. Microbes. Infect., 8, 1157, 10.1080/22221751.2019.1648183